Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tianjin Zhongxin Pharma Group | Singapore | Healthcare | Pharmaceuticals | SGD 4.28B | 6.2x | 0.09 | SGD 3.21 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Haw Par Corporation Ltd | Singapore | Healthcare | Pharmaceuticals | SGD 2.83B | 12.4x | 2.27 | SGD 12.77 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hyphens Pharma | Singapore | Healthcare | Pharmaceuticals | SGD 101.93M | 10x | 0.61 | SGD 0.33 | -2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.1% Upside | Upgrade to Pro+ | |
IX Biopharma Ltd | Singapore | Healthcare | Pharmaceuticals | SGD 18.65M | -1.7x | -0.3 | SGD 0.02 | 10.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pharmesis International Ltd | Singapore | Healthcare | Pharmaceuticals | SGD 14.74M | 9.4x | 0.04 | SGD 0.47 | -4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Suntar Eco-City Ltd | Singapore | Healthcare | Pharmaceuticals | SGD 8.10M | 5.5x | 0 | SGD 0.13 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |